Two thirds of health care leaders today are increasing telehealth capabilities, but in three years’ time artificial intelligence will be their main priority, says Philips’ latest annual Future Health Index.
Among the surprises to emerge from Royal Philips’ sixth annual survey of global health care leader sentiment as health care continues to evolve, the biggest was the new focus being placed on sustainability and environmental sourcing.
Running it close was the sense of optimism being expressed by executive officers, financial officers, technology and information officers and operations officers, whose views were sampled in December
After publishing encouraging results from first-in-human trials of its brain-computer interface, Axoft announced plans to sell its BCI-enabling material Fleuron to researchers and private organizations for R&D use. The company sees this as a revenue stream and feedback loop to refine its BCI platform designed for safer, longer-lasting brain implants.
Digital pathology makes it possible to unlock insights previously hidden to the human eye, “reshaping how we diagnose and treat patients,” said Nathan Buchbinder, co-founder and chief strategy officer at Proscia. He shared his views on the future of digital pathology and the lessons he has learned from working with pathologists.
“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”
